Format

Send to

Choose Destination
Blood Cancer J. 2017 Dec 20;7(12):659. doi: 10.1038/s41408-017-0023-x.

CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment.

Author information

1
Department of Pediatric Hematology/Oncology, CLIP, Charles University, Prague, Czech Republic.
2
Hematologic Pathology, Johns Hopkins University, Baltimore, MD, USA.
3
University of Toronto, Hospital for Sick Children, Toronto, ON, Canada.
4
Department of Pediatric Hematology, Robert Debre Hospital, Paris, France.
5
Pediatric Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
6
Global Development, Amgen Research (Munich) GmbH, Munich, Germany. gerhardz@amgen.com.
7
University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, USA.
8
Charité University Medical Center, Berlin, Germany.
9
Department of Pediatric Hematology-Oncology, IRCCS Ospedale Bambino Gesù, Rome, Italy.
10
University of Pavia, Pavia, Italy.
PMID:
29259173
PMCID:
PMC5802535
DOI:
10.1038/s41408-017-0023-x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center